LLY vs RVTY
Eli Lilly and Company vs Revvity — AI-powered side-by-side comparison
LLY
Eli Lilly and Company
68
Buy
VS
| Metric | LLY | RVTY |
|---|
| AI Score |
68
|
75
|
| Price |
$1,180.33
|
$116.77
|
| P/E Ratio |
39.54×
|
55.64×
|
| ROE |
77.8%
|
3.3%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
84.0%
|
52.1%
|
| Debt / Equity |
1.62×
|
0.46×
|
| Dividend Yield |
0.6%
|
0.2%
|
| RSI (14) |
57.1
|
65.1
|
| Beta |
0.506
|
1.072
|
| Expected Upside |
+5.8%
|
+1.3%
|
AI Committee View
Current Innellis committee reasoning for LLY versus RVTY.
RVTY leads by 7 points.
RVTY scores 75/100 (Buy) versus LLY at 68/100 (Buy).
LLY Committee View
75% agreement
4 analysts
The primary driver is vix regime is low -- calm backdrop supports risk-taking. The main limiting factor is growth rate is decelerating quarter over quarter -- the trend line matters more than the level. The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
RVTY Committee View
100% agreement
4 analysts
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is sector concentration is already high (hhi 2971.31). The committee is constructive but not yet at full conviction.
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- Stochastic RSI (92.1) confirms overbought conditions.
- Risk/reward is unfavorable: 28.5% downside vs 1.3% upside.